BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32387862)

  • 1. Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities.
    Rizvi SFA; Mu S; Wang Y; Li S; Zhang H
    Biomed Pharmacother; 2020 Jul; 127():110179. PubMed ID: 32387862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.
    Zheng Y; Ji S; Czerwinski A; Valenzuela F; Pennington M; Liu S
    Bioconjug Chem; 2014 Nov; 25(11):1925-41. PubMed ID: 25312799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin αvβ3 targeting activity study of different retro-inverso sequences of RGD and their potentiality in the designing of tumor targeting peptides.
    Liu Y; Mei L; Yu Q; Zhang Q; Gao H; Zhang Z; He Q
    Amino Acids; 2015 Dec; 47(12):2533-9. PubMed ID: 26173509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
    Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
    Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
    Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
    Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of self-assembled peptide nanoparticles for in vitro assessment of cell apoptosis pathway and in vivo therapeutic efficacy.
    Rizvi SFA; Mu S; Zhao C; Zhang H
    Mikrochim Acta; 2022 Jan; 189(2):53. PubMed ID: 34999971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Integrin αvβ3-Specific Ligand for the Sensitive Diagnosis of Glioblastoma.
    Zhang L; Shan X; Meng X; Gu T; Guo L; An X; Jiang Q; Ge H; Ning X
    Mol Pharm; 2019 Sep; 16(9):3977-3984. PubMed ID: 31306580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells.
    Chang MW; Lo JM; Juan HF; Chang HY; Chuang CY
    PLoS One; 2012; 7(5):e37935. PubMed ID: 22655084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
    Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
    Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new cyclic RGD peptide dimer for integrin αvβ3 imaging.
    Ma H; Hao P; Zhang L; Ma C; Yan P; Wang RF; Zhang CL
    Eur Rev Med Pharmacol Sci; 2016; 20(4):613-9. PubMed ID: 26957261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-angiogenesis activities of novel peptide complexes: mitochondria-disruptive 9mer peptides conjugated with the integrin alpha V beta 3-homing cyclic RGD motif.
    Iwasaki T; Yamakawa M; Asaoka A; Kawano T; Ishibashi J
    Biosci Biotechnol Biochem; 2012; 76(11):2044-8. PubMed ID: 23132564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiochemical Evaluation and
    Karimi H; Sadeghzadeh N; Abediankenari S; Rezazadeh F; Hallajian F
    Curr Radiopharm; 2017 Aug; 10(2):139-144. PubMed ID: 28681701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [
    Mohammadi R; Shokri B; Shamshirian D; Zarghi A; Shahhosseini S
    Daru; 2020 Jun; 28(1):87-96. PubMed ID: 31845157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel dual-cyclic RGD peptides for α
    Liu J; Cheng X; Tian X; Guan D; Ao J; Wu Z; Huang W; Le Z
    Bioorg Med Chem Lett; 2019 Apr; 29(7):896-900. PubMed ID: 30732943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.